Table 2.
LnSII | Events (%) | DES-ISR, OR (95% CI), P value | ||
---|---|---|---|---|
Model 1 | Model 2 | Model 3 | ||
Per 1-unit increase | 59 (11.3%) | 1.45 (1.02, 2.05), 0.037 | 1.77 (1.17, 2.66), 0.006 | 1.69 (1.04, 2.75), 0.034 |
Tertiles | ||||
T1 (< 6.1) | 10 (5.8%) | Ref. | Ref. | Ref. |
T2 (6.1–6.7) | 21 (12.1%) | 2.25 (1.03, 4.93), 0.042 | 2.46 (0.98, 6.21), 0.054 | 1.87 (0.70, 4.98), 0.213 |
T3 (≥ 6.7) | 28 (16.0%) | 3.12 (1.46, 6.65), 0.003 | 4.50 (1.83, 11.08), 0.001 | 3.69 (1.40, 9.70), 0.008 |
P for trend | 0.003 | < 0.001 | 0.006 | |
Categories | ||||
T1-2 (< 6.7) | 31 (8.9%) | Ref. | Ref. | Ref. |
T3 (≥ 6.7) | 28 (16.0%) | 1.95 (1.13, 3.36), 0.016 | 2.63 (1.38, 5.01), 0.003 | 2.52 (1.23, 5.17), 0.011 |
Model 1: crude model
Model 2: adjusted for age, gender, and body mass index
Model 3: adjusted for age, gender, body mass index, total cholesterol, low-density lipoprotein-C, hypertension, diabetes, length of stents, and minimal stent diameter. The covariates were selected based on the matched odds ratio changed at least 10% when added to this model
OR odds ratio, CI confidence interval DES drug-eluting stent, ISR in-stent restenosis, SII systemic immune-inflammation index